Cited by 847Lipoproteins and Cardiovascular HealthDiabetes, Cardiovascular Risks, and LipoproteinsCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women

Gardner, Christopher D.·1996·JAMA: The Journal of the American Medical Association

DOI 10.1001/jama.1996.03540110029028

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To investigate the prospective association of low-density lipoprotein (LDL) particle diameter with the incidence of fatal and nonfatal coronary artery disease (CAD). DESIGN: A nested case-control study. SETTING: Cases and controls were identified from a population-based sample of men and women combining all of the 5 cross-sectional surveys conducted from 1979 to 1990 of the Stanford Five-City Project (FCP). PARTICIPANTS: Incident CAD cases were identified through FCP surveillance between 1979 and 1992. Controls were matched by sex, 5-year age groups, survey time point, ethnicity, and FCP treatment condition. The sample included 124 matched pairs: 90 pairs of men and 34 pairs of women. MAIN OUTCOME MEASURES: LDL peak particle diameter (LDL size) was determined by gradient gel electrophoresis on plasma samples collected during the cross-sectional surveys (stored at 70 degrees C for 5-15 years). Established CAD risk-factor data were available from FCP baseline measurements. RESULTS: LDL size was smaller among CAD cases than controls (mean +/- SD) (26.17 +/- 1.00 nm vs 26.68 +/- 0.90 nm; P<.001). The association was graded across control quintiles of LDL size. The significant case-control difference in LDL size was independent of levels of high-density lipoprotein cholesterol (HDL-C), non-HDL cholesterol (non-HDL-C), triglyceride, smoking, systolic blood pressure, and body mass index, but was not significant after adjusting for the ratio of total cholesterol (TC) to HDL-C (TC:HDL-C). Among all the physiological risk factors, LDL size was the best differentiator of CAD status in conditional logistic regression. However, when added to the physiological parameters above, the TC:HDL-C ratio was found to be a stronger independent predictor of CAD status. CONCLUSION: LDL size was significantly smaller in CAD cases than in controls in a prospective, population-based study. These findings support other evidence of a role for small, dense LDL particles in the etiology of atherosclerosis.

Integrity signals

Registry

Crossref · 10.1001/jama.1996.03540110029028

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
Austin, M. A., King, M. C., Vranizan, K. M., & Krauss, R. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.495 · Cited by 1,411
Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.
Schuler, G. C., Hambrecht, R., Schlierf, G., Niebauer, J., Hauer, K. A., Neumann, J., Hoberg, E., Drinkmann, A., Bacher, F., & Grunze, M. F. (1992) · Circulation · doi:10.1161/01.cir.86.1.1 · Cited by 1,339
Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V, Knapp, E., Dunn, J. K., Gotto, A. M., & Patsch, W. (1992) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.12.11.1336 · Cited by 1,122
Identification of multiple subclasses of plasma low density lipoproteins in normal humans.
Krauss, R. M., & Burke, D. J. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38178-5 · Cited by 992
Role of Insulin Resistance in Human Disease (Syndrome X): An Expanded Definition
Reaven, G. M. (1993) · Annual Review of Medicine · doi:10.1146/annurev.me.44.020193.001005 · Cited by 908
NHLBI funding policies. Enhancing stability, predictability, and cost control.
Lenfant, C. L. (1994) · Circulation · doi:10.1161/01.cir.90.1.1 · Cited by 763
Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.
Graaf, J. D., Hak-Lemmers, H. L. M., Hectors, M. P. C., Demacker, P. N. M., Hendriks, J. C. M., & Stalenhoef, A. F. H. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.2.298 · Cited by 714
Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles.
Reaven, G. M., Chen, Y. I., Jeppesen, J., Maheux, P., & Krauss, R. M. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116541 · Cited by 687
Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B
Chait, A., Brazg, R., Tribble, D. L., & Krauss, R. M. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90144-e · Cited by 554

Show all 53 references

Sorted by citations

Items 101–200 of 847

Cholesteryl Ester Transfer Protein Taq I B2B2 Genotype Is Associated With Higher HDL Cholesterol Levels and Lower Risk of Coronary Heart Disease End Points in Men With HDL Deficiency
Brousseau, M. E., O’Connor, J. J., Ordovás, J. M., Collins, D. E., Otvos, J. D., Massov, T., McNamara, J. R., Bloomfield, H. E., Robins, S. J., & Schaefer, E. J. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000024566.57589.2e · Cited by 149
Fatty liver, insulin resistance, and dyslipidemia
Adiels, M., Taskinen, M., & Borén, J. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0011-4 · Cited by 147
Small low-density lipoproteins and vascular cell adhesion molecule-1 are increased in association with hyperlipidemia in preeclampsia
Hubel, C. A., Lyall, F., Weissfeld, L. A., Gandley, R. E., & Roberts, J. M. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90337-7 · Cited by 146
Oral Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Potential New Approach for Treating Coronary Artery Disease
Sikorski, J. A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058224l · Cited by 144
Association between Triglyceride to HDL-C Ratio (TG/HDL-C) and Insulin Resistance in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Ren, X., Chen, Z. A., Zheng, S., Tingting, H., Li, Y., Liu, W., & Hu, Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154345 · Cited by 141
Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation
Deighan, C. J., CASLAKE, M. J., McConnell, M., Boulton‐Jones, J. M., & Packard, C. J. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70255-1 · Cited by 140
Beyond Low-Density Lipoprotein Cholesterol
Mudd, J. O., Borlaug, B. A., Johnston, P. V., Kral, B. G., Rouf, R., Blumenthal, R. S., & Kwiterovich, P. O. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.045 · Cited by 136
Usefulness of Childhood Non–High Density Lipoprotein Cholesterol Levels Versus Other Lipoprotein Measures in Predicting Adult Subclinical Atherosclerosis: The Bogalusa Heart Study
Frontini, M., Srinivasan, S. R., Xu, J.-H., Tang, R., Bond, M. G., & Berenson, G. S. (2008) · PEDIATRICS · doi:10.1542/peds.2007-1472 · Cited by 136
Triglycerides and atherogenic lipoproteins: rationale for lipid management
Krauss, R. M. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00213-7 · Cited by 137
Low density lipoprotein size, pravastatin treatment, and coronary events.
Campos, H. (2001) · JAMA · doi:10.1001/jama.286.12.1468 · Cited by 132
Cholesterol Metabolism in CKD
Reiss, A. B., Voloshyna, I., Leon, J. D., Miyawaki, N., & Mattana, J. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.06.028 · Cited by 135
Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men
Austin, M. A., Rodriguez, B. L., McKnight, B., McNeely, M. J., Edwards, K. L., Curb, J. D., & Sharp, D. S. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00956-5 · Cited by 129
Relationship of Abdominal Visceral and Subcutaneous Adipose Tissue With Lipoprotein Particle Number and Size in Type 2 Diabetes
Sam, S., Haffner, S. M., Davidson, M. H., D’Agostino, R. B., Feinstein, S. B., Kondos, G. T., Pérez, A., & Mazzone, T. (2008) · Diabetes · doi:10.2337/db08-0157 · Cited by 130
“The alterations in lipoprotein particle number and size in DM2 and insulin resistance have been linked to increased risk for cardiovascular disease in both cross-sectional (3-9) as well as prospective studies (10,11).”
Approach to lipoprotein management in 2001 National Cholesterol Guidelines
Grundy, S. M. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02631-0 · Cited by 128
Chemistry and health beneficial effects of oolong tea and theasinensins
Weerawatanakorn, M., Hung, W., Pan, M., Li, S., Li, D., Wan, X., & Ho, C. (2015) · Food Science and Human Wellness · doi:10.1016/j.fshw.2015.10.002 · Cited by 125
New insight into the pathophysiology of lipid abnormalities in type 2 diabetes
Vergès, B. L. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70213-6 · Cited by 134
Effect of Estrogen on Very Low Density Lipoprotein and Low Density Lipoprotein Subclass Metabolism in Postmenopausal Women1
Campos, H., Walsh, B. W., Judge, H., & Sacks, F. M. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4437 · Cited by 125
“Although women with CHD tend to have smaller LDL particles (265 A) compared to controls (269 A), the mean LDL particle size in women with CHD corresponds to increased LDL II rather than LDL III as found in men ( 12 ).”
Background
Dietary and Genetic Probes of Atherogenic Dyslipidemia
Krauss, R. M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000186365.73973.f0 · Cited by 124
Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview
Suh, S. H., & Kim, S. W. (2023) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0067 · Cited by 138
“Due to their increased capacity to penetrate the arterial intima and increased susceptibility to oxidation, small dense LDL particles are known to be more atherogenic than the other LDL subfractions [22,26,27].”
Biologic markers as predictors of cardiovascular disease
Frishman, W. H. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00184-3 · Cited by 120
Smallest LDL Particles Are Most Strongly Related to Coronary Disease Progression in Men
Holl, L. G., Krauss, R. M., Williams, P. T., Superko, H. R., Haskell, W. L., Alderman, E. L., Patricia, J., & Blanche, P. J. (2015) · Cited by 122
Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases
Koba, S., Hirano, T., Ito, Y., Tsunoda, F., Yokota, Y., Ban, Y., Iso, Y., Suzuki, H., & Katagiri, T. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.002 · Cited by 121
Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia
McKenney, J. M., McCormick, L. S., Schaefer, E. J., Black, D. M., & Watkins, M. L. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01639-3 · Cited by 120
Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease
Szalai, C., Keszei, M., Duba, J., Prohászka, Z., Kozma, G. T., Császár, A., Balogh, S., Almássy, Z., Füst, G., & Czinner, A. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.12.003 · Cited by 120
“Elevated TGs are a common and important component of the so-called metabolic syndrome, which includes obesity, hypertension, hypertriglyceridemia, decrease HDL [12], predominance of small, dense LDL particles [13], impaired glucose tolerance, and insulin resistance, each of them predisposes to an increase risk to CAD.”
Background
Beyond LDL Cholesterol Reduction
Superko, H. R. (1996) · Circulation · doi:10.1161/01.cir.94.10.2351 · Cited by 119
Diagnosis and treatment of apolipoprotein B dyslipoproteinemias
Sniderman, A. D., Couture, P., & Graaf, J. D. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.50 · Cited by 118
Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study
Johnson, J. L., Slentz, C. A., Duscha, B. D., Samsa, G. P., McCartney, J. S., Houmard, J. A., & Kraus, W. E. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.05.018 · Cited by 114
“In particular, increased levels of small, dense LDL have been shown to be strongly associated with coronary artery disease risk [1,3,4,6,7,30].”
Background
LDL Size and Risk of Coronary Heart Disease in Elderly Men and Women
Mykkänen, L. M., Kuusisto, J., Haffner, S. M., Laakso, M., & Austin, M. A. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.11.2742 · Cited by 112
Lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy improve the prediction of coronary artery disease in Type 1 Diabetes. A prospective report from the Pittsburgh Epidemiology of Diabetes Complications Study
Soedamah‐Muthu, S. S., Chang, Y., Otvos, J. D., Evans, R. G., & Orchard, T. J. (2003) · Diabetologia · doi:10.1007/s00125-003-1094-8 · Cited by 111
“Although increased levels of triglycerides have been correlated to other atherogenic and prothrombotic changes such as increases in small dense LDL and decreases in HDL cholesterol [13, 14], the availability of these latter variables in the current analyses suggests that the VLDL subclass particles are indeed of prima…”
Background
Effects of extended-release niacin on lipoprotein subclass distribution
Morgan, J. M., Capuzzi, D. M., Baksh, R. I., INTENZO, C. M., Carey, C. M., Reese, D., & Walker, K. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00394-1 · Cited by 111
Epidemiologic aspects of lipid abnormalities
Criqui, M. H., & Golomb, B. A. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00212-5 · Cited by 158
The Impact of Postprandial Lipemia in Accelerating Atherothrombosis
Roche, H. M., & Gibney, M. J. (2000) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/204748730000700504 · Cited by 110
Triglyceride, small, dense low-density lipoprotein, and the atherogenic lipoprotein phenotype
Austin, M. A. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0021-4 · Cited by 110
“In late 1996 and early 1997, the first evidence from prospective epidemiologic studies of LDL particle size and CHD incidence was published [18, 43 ,44].”
BackgroundResultInfluential
Prospective, Intensive Study of Metabolic Changes Associated with 48 Weeks of Amprenavir‐Based Antiretroviral Therapy
Dubé, M. P., Qian, D., Edmondson‐Melançon, H., Sattler, F. R., Goodwin, D., Martinez, C., Williams, V. C., Johnson, D., & Buchanan, T. A. (2002) · Clinical Infectious Diseases · doi:10.1086/341489 · Cited by 110
“Importantly, there was no decrease in mean LDL particle size, which would be expected to further increase the atherogenic potential of dyslipidemia [27].”
Background
Maintenance of the LDL Cholesterol:HDL Cholesterol Ratio in an Elderly Population Given a Dietary Cholesterol Challenge
Greene, C. M., Zern, T. L., Wood, R. J., Shrestha, S., Aggarwal, D., Sharman, M. J., Volek, J. S., & Fernández, M. L. (2005) · Journal of Nutrition · doi:10.1093/jn/135.12.2793 · Cited by 109
“The Pattern B subclass has been associated with a 3-fold increase in CHD risk (13,39) and could be related to the ease with which the smaller LDL particle crosses the intima wall of the endothelium and its increased susceptibility to oxidation.”
Background
Dyslipidemia in Visceral Obesity
Chan, D. C., Barrett, P. H. R., & Watts, G. F. (2004) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200404040-00004 · Cited by 111
Lipoprotein subclasses and coronary artery calcium in postmenopausal women from the healthy women study
Mackey, R. H., Kuller, L. H., Sutton‐Tyrrell, K., Evans, R. G., Holubkov, R., & Matthews, K. A. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02636-x · Cited by 108
Coronary atherogenic risk factors in women
Stangl, V. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3329 · Cited by 108
“However, after adjustment for triglycerides (TG) or TC/HDL-C ratio, small sized LDL did not remain significantly associated [32] [33] .”
Background
New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease
Preston Mason, R. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0762-1 · Cited by 129
Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease
Quaschning, T., Krane, V., Metzger, T., & Wanner, C. (2001) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2001.27384 · Cited by 107
Effects of margarine compared with those of butter on blood lipid profiles related to cardiovascular disease risk factors in normolipemic adults fed controlled diets
Judd, J. T., Baer, D. J., Clevidence, B. A., Muesing, R. A., Clevidence, B. A., Chen, S. C., Weststrate, J. A., Clevidence, B. A., Meijer, G. W., Janet, W., et al. (1998) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.4.768 · Cited by 105
Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study
McNamara, J. R., Shah, P. K., Nakajima, K., Cupples, L. A., Wilson, P. W. F., Ordovás, J. M., & Schaefer, E. J. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.6.1224 · Cited by 105
“Previous assay development work by our laboratory has shown that some lipoprotein tests are affected by freezing (11, 49), whereas others are not ( 40 ).”
Background
LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women.
Theobald, H. E., Chowienczyk, P. J., Whittall, R., Humphries, S. E., & Sanders, T. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.4.558 · Cited by 101
A Ketogenic Low-Carbohydrate High-Fat Diet Increases LDL Cholesterol in Healthy, Young, Normal-Weight Women: A Randomized Controlled Feeding Trial
Burén, J., Ericsson, M., Damasceno, N., & Sjödin, A. (2021) · Nutrients · doi:10.3390/nu13030814 · Cited by 104
“Small, dense LDL particles are considered more atherogenic than large particles, as some previous epidemiological studies demonstrated that indi ‐ viduals with predominantly small LDL particles had greater CVD risk than those with predominantly large LDL particles [9–11].”
Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro
Younis, N. N., Charlton-Menys, V., Sharma, R., Soran, H., & Durrington, P. N. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.036 · Cited by 104
Pioglitazone Reduces Atherogenic Dense LDL Particles in Nondiabetic Patients With Arterial Hypertension
Winkler, K., Konrad, T., Füllert, S., Friedrich, I., Destani, R., Baumstark, M. W., Krebs, K., Wieland, H., & März, W. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2588 · Cited by 104
“9% smaller than in control subjects (11).”
LDL Particle Size Distribution Is Associated With Carotid Intima-Media Thickness in Healthy 50-Year-Old Men
Skoglund-Andersson, C., Tang, R., Bond, M. G., Fairé, U. D., Hamsten, A., & Karpe, F. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.10.2422 · Cited by 104
Metabolic abnormalities: triglyceride and low-density lipoprotein
Krauss, R. M., & Siri, P. W. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.016 · Cited by 102
“In most of these studies, however, the strength of this relationship was reduced substantially after adjustment for other risk factors (eg, triglyceride [23] and total/HDL-C [43]).”
Background
The Role of Dietary Cholesterol in Lipoprotein Metabolism and Related Metabolic Abnormalities: A Mini-review
Kapourchali, F. R., Gangadaran, S., Goulet, A., & Moghadasian, M. H. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.842887 · Cited by 109
“It is generally established that small dense LDL particles are more atherogenic than large LDL particles (Gardner et al., 1996).”
Background
Small LDL-Cholesterol is Superior to LDL-Cholesterol for Determining Severe Coronary Atherosclerosis
Koba, S., Yokota, Y., Hirano, T., Ito, Y., Ban, Y., Tsunoda, F., Sato, T., Shoji, M., Suzuki, H., Geshi, E., et al. (2008) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e572 · Cited by 102
Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study
Quispe, R., Elshazly, M. B., Zhao, D., Toth, P. P., Puri, R., Virani, S. S., Blumenthal, R. S., Martin, S. S., Jones, S. R., & Michos, E. D. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319862401 · Cited by 102
Men Classified as Hypo- or Hyperresponders to Dietary Cholesterol Feeding Exhibit Differences in Lipoprotein Metabolism
Herron, K. L., Vega‐López, S., Ramjiganesh, T., Fernández, M. L., Conde, K., & Shachter, N. S. (2003) · Journal of Nutrition · doi:10.1093/jn/133.4.1036 · Cited by 102
Atherogenic Lipoprotein Phenotype and Diet-Gene Interactions
Krauss, R. M. (2001) · Journal of Nutrition · doi:10.1093/jn/131.2.340s · Cited by 101
Changes in LDL Density across the Menopausal Transition
Carr, M. C., Kim, K. H., Zambon, A., Mitchell, E. S., Woods, N. F., Casazza, C. P., Purnell, J. Q., Hokanson, J. E., Brunzell, J. D., & Schwartz, R. S. (2000) · Journal of Investigative Medicine · doi:10.1177/108155890004800405 · Cited by 100
LDL Size in African Americans, Hispanics, and Non-Hispanic Whites
Haffner, S. M., Agostino, R. B. D., Goff, D. C., Howard, B. V., Festa, A., Saad, M. F., & Mykkänen, L. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.9.2234 · Cited by 99
Effects of caloric restriction on human physiological, psychological, and behavioral outcomes: highlights from CALERIE phase 2
Dorling, J. L., van Vliet, S., Huffman, K. M., Kraus, W. E., Bhapkar, M. V., Pieper, C. F., Stewart, T. M., Das, S. K., Racette, S. B., Roberts, S. B., et al. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuaa085 · Cited by 108
D IETARY AND G ENETIC E FFECTS ON L OW -D ENSITY L IPOPROTEIN H ETEROGENEITY
Krauss, R. M. (2001) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.21.1.283 · Cited by 99
Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles
Gazi, I. F., Tsimihodimos, V., Tselepis, A. D., Elisaf, M., & Mikhailidis, D. P. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.7.1.53 · Cited by 98
Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial
Sawada, T., Tsubata, H., Hashimoto, N., Takabe, M., Miyata, T., Aoki, K., Yamashita, S., Oishi, S., Osue, T., Yokoi, K., et al. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0437-y · Cited by 97
‘Lipoproteins, glycoxidation and diabetic angiopathy’
Jenkins, A. J., Best, J. D., Klein, R. L., & Lyons, T. J. (2004) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.491 · Cited by 96
“LDL [8,9], which is associated with and predictive of a two- to threefold increased risk of coronary artery disease (CAD), with increased carotid intimal-media thickness IMT) in the general population, and with endothelial”
Background
Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: triglycerides and blood viscosity
Rosenson, R. S., Shott, S., & Tangney, C. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00656-6 · Cited by 97
“protein (LDL) [6–8], high density lipoprotein (HDL)”
Lipoproteins: When size really matters
German, J. B., Smilowitz, J. T., & Zivkovic, A. M. (2006) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2005.11.006 · Cited by 97
An olive oil-rich diet results in higher concentrations of LDL cholesterol and a higher number of LDL subfraction particles than rapeseed oil and sunflower oil diets
Pedersen, A. T., Baumstark, M. W., Marckmann, P., Gylling, H., & Sandström, B. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32351-8 · Cited by 95
Non-HDL Cholesterol as a Measure of Atherosclerotic Risk
Packard, C. J., & Saitō, Y. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.6 · Cited by 95
Population frequency distribution of non–high-density lipoprotein cholesterol (third national health and nutrition examination survey [NHANES iii], 1988–1994)
Gardner, C. D., Winkleby, M. A., & Fortmann, S. P. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00918-8 · Cited by 95
Self-citation
Conditional Risk Factors for Atherosclerosis
Kullo, I. J., & Ballantyne, C. M. (2005) · Mayo Clinic Proceedings · doi:10.4065/80.2.219 · Cited by 93
Mechanisms Linking Nonalcoholic Fatty Liver Disease with Coronary Artery Disease
Nseir, W., Shalata, A., Marmor, A. T., & Assy, N. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1767-y · Cited by 93
“The presence of small dense LDL particles is associated with increased CVD risk [102].”
Background
Type 2 diabetes, dyslipidemia, and vascular risk: Rationale and evidence for correcting the lipid imbalance
Carmena, R. (2005) · American Heart Journal · doi:10.1016/j.ahj.2005.04.027 · Cited by 92
Smaller LDL particle size in women with polycystic ovary syndrome compared to controls
Dejager, S., Pichard, C., Giral, P., Bruckert, É., Federspield, M. C., Beucler, I., & Turpin, G. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01245.x · Cited by 92
Favorable Effects of Pioglitazone and Metformin Compared With Gliclazide on Lipoprotein Subfractions in Overweight Patients With Early Type 2 Diabetes
Lawrence, J. M., Reid, J., Taylor, G. T., Stirling, C., & Reckless, J. P. D. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.41 · Cited by 92
Is it LDL particle size or number that correlates with risk for cardiovascular disease?
Superko, H. R., & Gadesam, R. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-008-0059-2 · Cited by 91
“[ 25 ] / 1996 Healthy people CHD GGE LDL size Yes Yes”
Background
Effects of medium chain fatty acids (MCFA), myristic acid, and oleic acid on serum lipoproteins in healthy subjects
Temme, E. H. M., Mensink, R. P., & Hornstra, G. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37149-2 · Cited by 91
Phospholipase A2 and small, dense low-density lipoprotein
Hurt‐Camejo, E., Camejo, G., & Sartipy, P. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200010000-00004 · Cited by 90
Free fatty acids and type 2 diabetes mellitus
Wyne, K. L. (2003) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.09.004 · Cited by 90
Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use
Mora, S. (2009) · Circulation · doi:10.1161/circulationaha.108.819359 · Cited by 89
Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes
Berneis, K. K., Jeanneret, C., Muser, J., Felix, B., & Miserez, A. R. (2005) · Metabolism · doi:10.1016/j.metabol.2004.08.017 · Cited by 90
A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes
Davidsson, P., Hulthe, J., Fagerberg, B., Olsson, B., Hallberg, C., Dahllöf, B., & Camejo, G. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500161-jlr200 · Cited by 88
“The LDL phenotype of all participants was established by gradient gel electrophoresis as described previously (11, 25, 26).”
Method
Differing Associations of Lipid and Lipoprotein Disturbances With the Macrovascular and Microvascular Complications of Type 1 Diabetes
Chaturvedi, N., Fuller, J., Taskinen, M., & On behalf of the EURODIAB PCS Group (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2071 · Cited by 88
“assessment and treatment, but it is increasingly clear, particularly for type 2 diabetes, that triglyceride, perhaps via its association with small dense LDL, may be a more useful marker (20,21).”
Background
Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial
Otvos, J. D., SHALAUROVA, I. Y., Freedman, D. S., & Rosenson, R. S. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00544-5 · Cited by 88
Small differences in the effects of stearic acid, oleic acid, and linoleic acid on the serum lipoprotein profile of humans
Thijssen, M. A. M. A., & Mensink, R. P. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.3.510 · Cited by 87
Dyslipidemia and renal disease: pathogenesis and clinical consequences
Wanner, C., & Quaschning, T. (2001) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200103000-00007 · Cited by 87
High insulin levels and increased low‐density lipoprotein oxidizability in pediatric patients with systemic lupus erythematosus
Posadas‐Romero, C., Torres‐Tamayo, M., Zamora‐González, J., Aguilar-Herrera, B. E., Posadas‐Sánchez, R., Cardoso-Saldaña, G. C., de Guevara, G. L., Solís-Vallejo, E., & Hafidi, M. E. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11472 · Cited by 86
Should we measure routinely the LDL peak particle size?
Rizzo, M., & Berneis, K. K. (2005) · International Journal of Cardiology · doi:10.1016/j.ijcard.2005.02.035 · Cited by 86
A Genome Search Identifies Major Quantitative Trait Loci on Human Chromosomes 3 and 4 That Influence Cholesterol Concentrations in Small LDL Particles
Rainwater, D. L., Almasy, L. A., Blangero, J., Cole, S. A., VandeBerg, J. L., MacCluer, J. W., & Hixson, J. E. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.3.777 · Cited by 86
Plasma LDL and HDL characteristics and carotenoid content are positively influenced by egg consumption in an elderly population1
Greene, C. M., Waters, D. D., Clark, R. M., Contois, J. H., & Fernández, M. L. (2006) · Nutrition & Metabolism · doi:10.1186/1743-7075-3-6 · Cited by 85
“It has been reported that LDL size was the best predictor of coronary artery disease [ 34 ,35] and the increase in cardiovascular risk, attributable to lipid factors, was significantly modulated by variations in LDL particle size [32,36].”
Background
Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin
Mason, R. P., Dawoud, H., Jacob, R. F., Sherratt, S. C. R., & Maliñski, T. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.118 · Cited by 87
Oolong tea increases plasma adiponectin levels and low-density lipoprotein particle size in patients with coronary artery disease
Shimada, K., Kawarabayashi, T., Tanaka, A., Fukuda, D., Nakamura, Y., Yoshiyama, M., Takeuchi, K., Sawaki, T., Hosoda, K., & Yoshikawa, J. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.01.003 · Cited by 84
“On the other hand, the accumulated evidence of a number of studies suggests that low-density lipoprotein (LDL) particle size is a risk factor for CAD [9–12].”
Background
The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndrome
Filippatos, T. D., Gazi, I. F., Liberopoulos, E. N., Athyros, V. G., Elisaf, M., Tselepis, A. D., & Kiortsis, D. N. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.07.010 · Cited by 84
Fibrate Therapy
Remick, J. S., WEINTRAUB, H. S., Setton, R. A., Offenbacher, J., Fisher, E. A. A., & Schwartzbard, A. Z. (2008) · Cardiology in Review · doi:10.1097/crd.0b013e31816b43d3 · Cited by 83
A practical approach to risk assessment to prevent coronary artery disease and its complications
Linton, M. F., & Fazio, S. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00505-8 · Cited by 83
High intake of cholesterol results in less atherogenic low-density lipoprotein particles in men and women independent of response classification
Herron, K. L., Lofgren, I. E., Sharman, M. J., Volek, J. S., & Fernández, M. L. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.030 · Cited by 83
Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation: A systematic review and meta-analysis
Hong, C. G., Florida, E. M., Li, H., Parel, P. M., Mehta, N. N., & Sorokin, A. V. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1023651 · Cited by 88
Utility of Non–High-Density Lipoprotein Cholesterol Versus Other Lipoprotein Measures in Detecting Subclinical Atherosclerosis in Young Adults (The Bogalusa Heart Study)
Frontini, M., Srinivasan, S. R., Xu, J.-H., Tang, R., Bond, M. G., & Berenson, G. S. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.01.071 · Cited by 80
Exercise training, postprandial hypertriglyceridemia, and LDL subfraction distribution
ZIOGAS, G. G., THOMAS, T. R., & HARRIS, W. S. (1997) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199708000-00002 · Cited by 79
Dyslipoproteinaemia in postmenopausal women with a history of eclampsia
Hubel, C. A., Snaedal, S., Ness, R. B., Weissfeld, L. A., Geirsson, R. T., Roberts, J. M., & Arngrı́msson, R. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb13340.x · Cited by 79
Small, Dense Lipoprotein Particles and Reduced Paraoxonase-1 in Patients with the Metabolic Syndrome
Blatter, M.-C., Kalix, B., Morabia, A., & James, R. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1295 · Cited by 79
“Both quantitative and qualitative changes to lipoprotein profiles contribute to the increased incidence of coronary disease (12).”
Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful
Superko, H. R. (2009) · Circulation · doi:10.1161/circulationaha.108.809582 · Cited by 78
Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria
Gazi, I. F., Tsimihodimos, V., Filippatos, T. D., Bairaktari, E. T., Tselepis, A. D., & Elisaf, M. (2006) · Metabolism · doi:10.1016/j.metabol.2006.02.015 · Cited by 75
Narrowing Sex Differences in Lipoprotein Cholesterol Subclasses Following Mid‐Life: The Very Large Database of Lipids (VLDL‐10B)
Swiger, K. J., Martin, S. S., Blaha, M. J., Toth, P. P., Nasir, K., Michos, E. D., Gerstenblith, G., Blumenthal, R. S., & Jones, S. R. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.000851 · Cited by 77
Levels and correlates of LDL and VLDL particle sizes among children: the Bogalusa heart study
Freedman, D. S., Bowman, B. A., Otvos, J. D., Srinivasan, S. R., & Berenson, G. S. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00495-5 · Cited by 77
“Although there are several mechanisms by which small LDL particles could promote atherosclerosis [27,28], many (but not all [9]) investigators have found that adjustment for lipid levels greatly reduces the magnitude of the association with CHD risk [7,8].”
Background

Authors: Gardner, C. D.
Affiliations: Stanford Medicine (US)
Corresponding author: Gardner, Christopher D.
ORCID: Gardner, Christopher D.
Venue: JAMA: The Journal of the American Medical Association
Publisher: American Medical Association (AMA)
Published: 1996-09-18
Volume: 276
Issue: 11
Pages: 875
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.1996.03540110029028
OpenAlex: W2050758709
Cited by: 843
References: 53
Citations by year: 2026: 3 · 2025: 4 · 2024: 5 · 2023: 10 · 2022: 10 · 2021: 16 · 2020: 23 · 2019: 14 · 2018: 7 · 2017: 16 · 2016: 10 · 2015: 23 · 2014: 14 · 2013: 33 · 2012: 22
FWCI: 37.88
Type: journal article
Language: en
Open access: closed
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5p01hl018574-26, 5r01hl021906-19)
National Heart, Lung, and Blood Institute (T32HL007034, HL21906, HL-18574, 5 T32 HL07034)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: small dense LDL, LDL particle size, coronary artery disease, atherosclerosis, cardiovascular risk factors, TC/HDL-C ratio, HDL cholesterol, non-HDL cholesterol, triglycerides, sex differences
MeSH terms: Adult, Aged, Coronary Disease, Cross-Sectional Studies, Electrophoresis, Polyacrylamide Gel, Female, Humans, Lipids, Lipoproteins, LDL, Male, Middle Aged, Prospective Studies, Risk Factors, Body Mass Index, Incidence, Linear Models, Logistic Models, Case-Control Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks